{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:10:14Z","timestamp":1776823814480,"version":"3.51.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"General Program of National Natural Science Foundation of China","award":["81372371"],"award-info":[{"award-number":["81372371"]}]},{"name":"Zhongyuan Scholars Program of Henan Province","award":["162101510006"],"award-info":[{"award-number":["162101510006"]}]},{"name":"the Major Project of Science and Technology in Henan Province","award":["16110311400"],"award-info":[{"award-number":["16110311400"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00432-019-02884-5","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T10:03:06Z","timestamp":1552903386000},"page":"1253-1262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer"],"prefix":"10.1007","volume":"145","author":[{"given":"Jiejie","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binghua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2938-9526","authenticated-orcid":false,"given":"Jianying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"2884_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/172460080802300406","volume":"23","author":"U Bajpai","year":"2008","unstructured":"Bajpai U, Sharma R, Kausar T, Dattagupta S, Chattopadhayay TK, Ralhan R (2008) Clinical significance of 14-3-3 zeta in human esophageal cancer. The International journal of biological markers 23:231\u2013237","journal-title":"The International journal of biological markers"},{"key":"2884_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.15386\/cjmed-409","volume":"88","author":"C Cainap","year":"2015","unstructured":"Cainap C, Nagy V, Gherman A, Cetean S, Laszlo I, Constantin AM, Cainap S (2015) Classic tumor markers in gastric cancer. Current standards limitations Clujul medical 88:111\u2013115. https:\/\/doi.org\/10.15386\/cjmed-409","journal-title":"Current standards limitations Clujul medical"},{"key":"2884_CR3","first-page":"2311","volume":"22","author":"M Carpelan-Holmstrom","year":"2002","unstructured":"Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Haglund C (2002) CEA, CA 19 \u2013 9 and CA 72 \u2013 4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer research 22:2311\u20132316","journal-title":"Anticancer research"},{"key":"2884_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD et al (2016) Cancer statistics in China, 2015. CA: a cancer journal for clinicians 66:115\u2013132. https:\/\/doi.org\/10.3322\/caac.21338","journal-title":"CA: a cancer journal for clinicians"},{"key":"2884_CR5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0094-0143(21)00910-1","volume":"20","author":"WH Cooner","year":"1993","unstructured":"Cooner WH (1993) Definition of the ideal tumor marker. The Urologic clinics of North America 20:575\u2013579","journal-title":"The Urologic clinics of North America"},{"key":"2884_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2162-3619-2-15","volume":"2","author":"LP Dai","year":"2013","unstructured":"Dai LP, Lei NJ, Liu M, Zhang JY (2013) Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC). Experimental hematology oncology 2:15. https:\/\/doi.org\/10.1186\/2162-3619-2-15","journal-title":"Experimental hematology oncology"},{"key":"2884_CR7","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/pros.23217","volume":"76","author":"LP Dai","year":"2016","unstructured":"Dai LP, Li JT, Xing MT, Sanchez TW, Casiano CA, Zhang JY (2016a) Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer. Prostate 76:1375\u20131386. https:\/\/doi.org\/10.1002\/pros.23217","journal-title":"Prostate"},{"key":"2884_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.lungcan.2016.07.018","volume":"99","author":"LP Dai","year":"2016","unstructured":"Dai LP, Tsay JC, Li JT et al (2016b) Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung cancer 99:172\u2013179. https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.018","journal-title":"Lung cancer"},{"key":"2884_CR9","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1158\/0008-5472.CAN-03-2646","volume":"64","author":"EA Danna","year":"2004","unstructured":"Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S (2004) Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer research 64:2205\u20132211","journal-title":"Cancer research"},{"key":"2884_CR10","first-page":"400","volume":"81","author":"L Fernandez-Fernandez","year":"1996","unstructured":"Fernandez-Fernandez L, Tejero E, Tieso A, Rabadan L, Munoz M, Santos I (1996) Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19 \u2013 9 and CA 72 \u2013 4 in gastric cancer. International surgery 81:400\u2013402","journal-title":"International surgery"},{"key":"2884_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-2007-1023900","volume":"123","author":"U Gartner","year":"1998","unstructured":"Gartner U, Scheulen ME, Conradt C, Wiefelsputz J, Kruck P, Aghabi E, Delbruck H (1998) Value of tumor-associated antigens CA 72 \u2013 4 vs. CEA and CA 19 \u2013 9 in the follow-up after stomach cancer. Deutsche medizinische Wochenschrift 123:69\u201373. https:\/\/doi.org\/10.1055\/s-2007-1023900","journal-title":"Deutsche medizinische Wochenschrift"},{"key":"2884_CR12","doi-asserted-by":"publisher","first-page":"e40594","DOI":"10.1371\/journal.pone.0040594","volume":"7","author":"A Goc","year":"2012","unstructured":"Goc A, Abdalla M, Al-Azayzih A, Somanath PR (2012) Rac1 activation driven by 14-3-3zeta dimerization promotes prostate cancer cell-matrix interactions, motility and transendothelial migration. PloS one 7:e40594. https:\/\/doi.org\/10.1371\/journal.pone.0040594","journal-title":"PloS one"},{"key":"2884_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cca.2008.03.017","volume":"393","author":"B Hamrita","year":"2008","unstructured":"Hamrita B, Chahed K, Kabbage M, Guillier CL, Trimeche M, Chaieb A, Chouchane L (2008) Identification of tumor antigens that elicit a humoral immune response in breast cancer patients\u2019 sera by serological proteome analysis (SERPA) Clinica chimica acta. International journal of clinical chemistry 393:95\u2013102. https:\/\/doi.org\/10.1016\/j.cca.2008.03.017","journal-title":"International journal of clinical chemistry"},{"key":"2884_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(09)60617-6","volume":"374","author":"HH Hartgrink","year":"2009","unstructured":"Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ (2009) Gastric cancer. Lancet 374:477\u2013490. https:\/\/doi.org\/10.1016\/S0140-6736(09)60617-6","journal-title":"Lancet"},{"key":"2884_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1757-2215-6-79","volume":"6","author":"I Hatzipetros","year":"2013","unstructured":"Hatzipetros I et al (2013) Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer. Journal of ovarian research 6:79. https:\/\/doi.org\/10.1186\/1757-2215-6-79","journal-title":"Journal of ovarian research"},{"key":"2884_CR16","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1021\/pr100822v","volume":"9","author":"Y He","year":"2010","unstructured":"He Y, Wu X, Liu X, Yan G, Xu C (2010) LC-MS\/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker. Journal of proteome research 9:6180\u20136190. https:\/\/doi.org\/10.1021\/pr100822v","journal-title":"Journal of proteome research"},{"key":"2884_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cas.13158","volume":"108","author":"I Hoshino","year":"2017","unstructured":"Hoshino I, Nagata M, Takiguchi N et al (2017) Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer. Cancer science 108:308\u2013315. https:\/\/doi.org\/10.1111\/cas.13158","journal-title":"Cancer science"},{"key":"2884_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5230\/jgc.2018.18.e7","volume":"18","author":"JH Kim","year":"2018","unstructured":"Kim JH, Kim SS, Lee JH, Jung DH, Cheung DY, Chung WC, Park SH (2018) Early Detection is Important to Reduce the Economic Burden of Gastric Cancer. Journal of gastric cancer 18:82\u201389. https:\/\/doi.org\/10.5230\/jgc.2018.18.e7","journal-title":"Journal of gastric cancer"},{"key":"2884_CR19","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1007\/s13277-013-1555-8","volume":"35","author":"M Liu","year":"2014","unstructured":"Liu M, Liu XX, Ren PF et al (2014) A cancer-related protein 14-3-3zeta is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma. Tumour biology 35:4247\u20134256. https:\/\/doi.org\/10.1007\/s13277-013-1555-8","journal-title":"Tumour biology"},{"key":"2884_CR20","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.3892\/mmr.2017.7496","volume":"16","author":"XX Liu","year":"2017","unstructured":"Liu XX, Ye H, Wang P, Zhang Y, Zhang JY (2017) Identification of 1433zeta as a potential biomarker in gastric cancer by proteomics based analysis. Molecular medicine reports 16:7759\u20137765. https:\/\/doi.org\/10.3892\/mmr.2017.7496","journal-title":"Molecular medicine reports"},{"key":"2884_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cca.2006.10.024","volume":"378","author":"B Lu","year":"2007","unstructured":"Lu B, Xu J, Zhu Y, Zhang H, Lai M (2007) Systemic analysis of the differential gene expression profile in a colonic adenoma-normal SSH library Clinica chimica acta. International journal of clinical chemistry 378:42\u201347. https:\/\/doi.org\/10.1016\/j.cca.2006.10.024","journal-title":"International journal of clinical chemistry"},{"key":"2884_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1471-2407-7-169","volume":"7","author":"A Matta","year":"2007","unstructured":"Matta A, Bahadur S, Duggal R, Gupta SD, Ralhan R (2007) Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer 7:169. https:\/\/doi.org\/10.1186\/1471-2407-7-169","journal-title":"BMC Cancer"},{"key":"2884_CR23","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1158\/1055-9965.EPI-17-0238","volume":"26","author":"I Meistere","year":"2017","unstructured":"Meistere I, Werner S, Zayakin P et al (2017) The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions. Cancer epidemiology biomarkers prevention 26:1564\u20131574. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-0238","journal-title":"Cancer epidemiology biomarkers prevention"},{"key":"2884_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.7150\/jca.21562","volume":"9","author":"S Ning","year":"2018","unstructured":"Ning S, Wei W, Li J et al (2018) Explore the diagnostic value of joint detection of thymidine kinase 1 (TK1), carcinoembryonic antigen (CEA), carbohydrate antigen 19 \u2013 9 (CA 19 \u2013 9) and carbohydrate antigen 72 \u2013 4 (CA 72 \u2013 4) in the diagnosis of GC. Journal of Cancer 9:494\u2013501. https:\/\/doi.org\/10.7150\/jca.21562","journal-title":"Journal of Cancer"},{"key":"2884_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/bjc.2013.65","volume":"108","author":"Y Nishimura","year":"2013","unstructured":"Nishimura Y et al (2013) Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma. Br J Cancer 108:1324\u20131331. https:\/\/doi.org\/10.1038\/bjc.2013.65","journal-title":"Br J Cancer"},{"key":"2884_CR26","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1158\/0008-5472.CAN-13-0578","volume":"73","author":"S Oh","year":"2013","unstructured":"Oh S, Shin S, Lightfoot SA, Janknecht R (2013) 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer. Cancer research 73:5110\u20135119. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0578","journal-title":"Cancer research"},{"key":"2884_CR27","doi-asserted-by":"publisher","first-page":"9018","DOI":"10.1158\/0008-5472.CAN-04-3262","volume":"64","author":"J Shen","year":"2004","unstructured":"Shen J, Person MD, Zhu J, Abbruzzese JL, Li D (2004) Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer research 64:9018\u20139026. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3262","journal-title":"Cancer research"},{"key":"2884_CR28","first-page":"17","volume":"7","author":"A Suzuki","year":"2010","unstructured":"Suzuki A, Lizuka A, Komiyama M et al (2010) Identification of melanoma antigens using a Serological Proteome Approach (SERPA). Cancer genomics proteomics 7:17\u201323","journal-title":"Cancer genomics proteomics"},{"key":"2884_CR29","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/S0140-6736(16)30354-3","volume":"388","author":"E Cutsem Van","year":"2016","unstructured":"Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H (2016) Gastric cancer Lancet 388:2654\u20132664. https:\/\/doi.org\/10.1016\/S0140-6736(16)30354-3","journal-title":"Gastric cancer Lancet"},{"key":"2884_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ejso.2013.09.020","volume":"40","author":"T Waddell","year":"2014","unstructured":"Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D (2014) Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. European journal of surgical oncology 40:584\u2013591. https:\/\/doi.org\/10.1016\/j.ejso.2013.09.020","journal-title":"European journal of surgical oncology"},{"key":"2884_CR31","doi-asserted-by":"publisher","unstructured":"Wang SB, Qin JJ, Ye H et al (2018) Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer. Oncoimmunology e1452582. https:\/\/doi.org\/10.1080\/2162402x.2018.1452582","DOI":"10.1080\/2162402x.2018.1452582"},{"key":"2884_CR32","doi-asserted-by":"publisher","first-page":"25467","DOI":"10.1038\/srep25467","volume":"6","author":"S Werner","year":"2016","unstructured":"Werner S, Chen H, Butt J et al (2016) Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer. Scientific reports 6:25467. https:\/\/doi.org\/10.1038\/srep25467","journal-title":"Scientific reports"},{"key":"2884_CR33","first-page":"6740","volume":"62","author":"JD Wulfkuhle","year":"2002","unstructured":"Wulfkuhle JD, Sgroi DC, Krutzsch H et al (2002) Proteomics of human breast ductal carcinoma in situ. Cancer research 62:6740\u20136749","journal-title":"Cancer research"},{"key":"2884_CR34","first-page":"263","volume":"32","author":"MX Xu","year":"2018","unstructured":"Xu MX, Cui HJ, Yao TL, Gui YF (2018) Clinical value of combined tests for tumor markers for gastric cancer. Journal of biological regulators homeostatic agents 32:263\u2013268","journal-title":"Journal of biological regulators homeostatic agents"},{"key":"2884_CR35","first-page":"136","volume":"12","author":"JY Zhang","year":"2003","unstructured":"Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM (2003) Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens Cancer epidemiology. biomarkers prevention 12:136\u2013143","journal-title":"biomarkers prevention"},{"key":"2884_CR36","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/bcr2091","volume":"10","author":"L Zhong","year":"2008","unstructured":"Zhong L, Ge K, Zu JC et al (2008) Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res 10:R40. https:\/\/doi.org\/10.1186\/bcr2091","journal-title":"Breast Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-02884-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T23:03:46Z","timestamp":1663110226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-02884-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2884"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-02884-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"3 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}